Skip to content

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02862756
Acronym
ACET
Enrollment
250
Registered
2016-08-11
Start date
2016-11-14
Completion date
2021-03-09
Last updated
2021-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unruptured Intracranial Aneurysms

Brief summary

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

Detailed description

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.

Interventions

OTHERdiffusion-weighted MRI and clinical examination

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient having a programmed endovascular treatment for unruptured intracranial aneurysm * patient older than 18 years * patient consenting to participate to the study * patient enrolled in the national healthcare insurance program

Exclusion criteria

* patients with contraindications for MRI * patients whose clinical condition does not allow sufficient cooperation to the realization of MRI * patients with arteriovenous malformation intracranial

Design outcomes

Primary

MeasureTime frameDescription
Thromboembolic complication72 hours after endovascular treatmentThromboembolic complication diagnosed using diffusion-weighted MRI

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026